Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Edoxudine

Copy Product Info
😃Good
Catalog No. T4374Cas No. 15176-29-1
Alias EUDR, Epoxudine, Aedurid

Edoxudine (Epoxudine), an antiviral drug, is an analogue of thymidine and shows effectiveness against the herpes simplex virus. Edoxudine is used as a 5-fluorouracil (FU) modulator. Edoxudine may be used to enhance the therapeutic index of 5-FU by reducing the catabolism, prolonging the plasma and intratumoral concentrations of 5-FU, and offering protection to normal organs by increasing the endogenous uridine levels. It can also enhance the antitumour action of 5-FU.

Edoxudine

Edoxudine

Copy Product Info
😃Good
Purity: 99.94%
Catalog No. T4374Alias EUDR, Epoxudine, AeduridCas No. 15176-29-1
Edoxudine (Epoxudine), an antiviral drug, is an analogue of thymidine and shows effectiveness against the herpes simplex virus. Edoxudine is used as a 5-fluorouracil (FU) modulator. Edoxudine may be used to enhance the therapeutic index of 5-FU by reducing the catabolism, prolonging the plasma and intratumoral concentrations of 5-FU, and offering protection to normal organs by increasing the endogenous uridine levels. It can also enhance the antitumour action of 5-FU.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
10 mg$35In StockIn Stock
25 mg$71In StockIn Stock
50 mg$113In StockIn Stock
100 mg$197-In Stock
1 mL x 10 mM (in DMSO)$29In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.94%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Edoxudine AI Summary
Edoxudine exhibits potent antiviral activity against various strains of herpes simplex virus (HSV-1 and HSV-2) with increasing inhibition rates as the concentration increases, achieving up to 100% inhibition at specific concentrations. It reduces plaque formation significantly in human embryonic lung fibroblast (HELF) and vero cells, with ID50 values ranging between 10.0 µM and 40.0 µM and MIC50 values from 20.0 µg/mL to 140000.0 nM. Notably, it also demonstrates low cytotoxicity in HELF, human foreskin fibroblast cells, and African green monkey Vero cells, with CC50 values greater than 780000.0 nM and 200.0 µg/mL. Furthermore, compound 169382 possesses selective antiviral effects against a broader range of viruses, including vaccinia virus, varicella-zoster virus (VZV), and Epstein-Barr virus (EBV), exhibiting EC50 values from 600.0 nM to 66400.0 nM. Against Mycobacterium tuberculosis, it shows inhibitory activity on thymidine monophosphate kinase (TMPK) with a Ki value of 1140000.0 nM. The compound also demonstrates cytostatic activity against L1210/0 and Raji/0 cells with ID50 values of 1.6 and 2.9 µg/mL respectively. Edoxudine's antiviral properties extend to SARS-CoV-2, where it prevents virus-induced cytotoxicity in Caco-2 and VERO-6 cells, although its potency remains relatively low with observed IC50 values greater than 100000.0 nM. It has been tested as a 3CL-Pro protease inhibitor for SARS-CoV-2, showing partial inhibition at 20 µM. In addition, it inhibits DNA repair enzymes, sodium fluorescein uptake in OATP-transfected CHO cells, and displays moderate cytotoxicity against select human cell lines, supporting its potential therapeutic implications in viral infection control and enzyme inhibition..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Edoxudine (Epoxudine), an antiviral drug, is an analogue of thymidine and shows effectiveness against the herpes simplex virus. Edoxudine is used as a 5-fluorouracil (FU) modulator. Edoxudine may be used to enhance the therapeutic index of 5-FU by reducing the catabolism, prolonging the plasma and intratumoral concentrations of 5-FU, and offering protection to normal organs by increasing the endogenous uridine levels. It can also enhance the antitumour action of 5-FU.
SynonymsEUDR, Epoxudine, Aedurid
Chemical Properties
Molecular Weight256.26
FormulaC11H16N2O5
Cas No.15176-29-1
SmilesCCc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O
Relative Density.1.389 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 45 mg/mL (175.6 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.8 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.9023 mL19.5114 mL39.0229 mL195.1143 mL
5 mM0.7805 mL3.9023 mL7.8046 mL39.0229 mL
10 mM0.3902 mL1.9511 mL3.9023 mL19.5114 mL
20 mM0.1951 mL0.9756 mL1.9511 mL9.7557 mL
50 mM0.0780 mL0.3902 mL0.7805 mL3.9023 mL
100 mM0.0390 mL0.1951 mL0.3902 mL1.9511 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Edoxudine | purchase Edoxudine | Edoxudine cost | order Edoxudine | Edoxudine chemical structure | Edoxudine formula | Edoxudine molecular weight